Event Brief
Jan 21, 2026 at 8:02 AM ET
J&J Expects $100 Billion Revenue Next Year
By The BriefBrief
Johnson & Johnson sees 9% revenue growth in Q4, driven by cancer drugs.
WHO: Johnson & Johnson
WHAT: Revenue growth and new strategy implementation
WHEN: Jan 21, 2026 at 7:26 AM ET
WHERE: United States
WHY: Strength in cancer drug sales
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21418 of 21418
Same format. Every time.
Continue reading — sign in or create a free account with
